SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-075796
Filing Date
2010-04-02
Accepted
2010-04-02 13:17:44
Documents
5
Period of Report
2010-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 22456
2 FOURTH AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES dex101.htm EX-10.1 26471
3 AMENDED AND RESTATED SUNESIS PHARMACEUTICALS, INC. 2009 BONUS PROGRAM dex102.htm EX-10.2 18025
4 PRESS RELEASE, DATED APRIL 1, 2010 dex991.htm EX-99.1 6778
5 GRAPHIC g64556g40k88.jpg GRAPHIC 2145
  Complete submission text file 0001193125-10-075796.txt   78801
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 10727511
SIC: 2834 Pharmaceutical Preparations